[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1973

New Therapy for Polymorphous Light Eruption

Author Affiliations

New Haven, Conn; West Haven, Conn; Boston

From the Department of Dermatology, Yale University School of Medicine, New Haven, Conn (Dr. Nordlund); the Department of Medicine, Veterans Administration Hospital, West Haven, Conn (Dr. Klaus); the Channing Laboratory, Thorndike Memorial Laboratory, Harvard Medical Unit, Department of Microbiology, Boston City Hospital (Dr. Mathews-Roth); the departments of microbiology and molecular genetics (Dr. Mathews-Roth) and dermatology (Dr. Pathak), Harvard Medical School, Boston; and the Department of Dermatology, Massachusetts General Hospital, Boston (Dr. Pathak).

Arch Dermatol. 1973;108(5):710-712. doi:10.1001/archderm.1973.01620260058024
Abstract

A patient suffering from polymorphous light eruption did not respond to conventional modes of therapy. Phototesting demonstrated that he was sensitive to light from 290 to 500 nm. The patient was treated with a combination of sulisobenzone and β-carotene, with amelioration of the disease.

×